Zacks Investment Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-32,330
Closed -$6.46M 581
2020
Q4
$6.46M Buy
32,330
+5,693
+21% +$1.16M 0.12% 143
2020
Q3
$5.84M Buy
26,637
+19,394
+268% +$4.11M 0.12% 135
2020
Q2
$1.38M Buy
7,243
+5,282
+269% +$926K 0.03% 253
2020
Q1
$304K Buy
+1,961
New +$228K 0.01% 430

Other funds holding TDOC

Zacks Investment Management's TDOC Position: Q1 2021 in Review

Zacks Investment Management sold out of Teladoc Health (TDOC) in Q1 2021, closing a stake of 32,330 shares — an estimated $6.46M sold.

Zacks Investment Management first reported a position in TDOC in Q1 2020 and held it in 4 quarters. The position peaked at $6.46M in Q4 2020. 889 funds tracked by Wall St. Rank hold TDOC as of Q1 2021.

  • Zacks Investment Management reported no remaining Teladoc Health position as of Q1 2021 after selling out during the quarter.
  • Zacks Investment Management sold 32,330 Teladoc Health shares in Q1 2021, an estimated $6.46M.
  • Zacks Investment Management first reported a position in Teladoc Health in Q1 2020 and held it in 4 quarters.
  • Zacks Investment Management's Teladoc Health position peaked at $6.46M in Q4 2020.
  • 889 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2021.

Based on Zacks Investment Management's 13F filing for Q1 2021, filed 17 May 2021.